COVID-19 dermatological manifestations

Broshtilova Valentina; Stratieva Dalia; Kantardjiev Vessel

doi:10.30574/gscarr.2021.7.3.0130

Authors

Broshtilova Valentina Department of Dermatology and Venereology, Military Medical Academy, Sofia, Bulgaria.
Stratieva Dalia Department of Dermatology and Venereology, Military Medical Academy, Sofia, Bulgaria.
Kantardjiev Vessel Department of Dermatology and Venereology, Military Medical Academy, Sofia, Bulgaria.

DOI:

https://doi.org/10.30574/gscarr.2021.7.3.0130

Keywords:

COVID-19, Skin lesions, Dermatological features

Abstract

COVID-19 is an ongoing multisystemic viral infection, which affects both adults and children. The virus has a complicated and not fully understood pathophysiological mechanism of damaging different organs and systems, including the skin. Cutaneous manifestations classification is complicated by the great variety of lesions and histological appearances, neither specific. Herein, a thorough overview of the clinical and pathological peculiarities of skin changes observed in the acute and re-convalescent stages of COVID-19 infection, is highlighted. The pathophysiological mechanisms, suggested to trigger and sustain the dermatological dysfunction, are also considered in the vicinity of authors’ personal experience.

Metrics

Metrics Loading ...

References

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, etal. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395: 565–574.

She J, Liu L, Liu W. COVID-19 epidemic: disease characteristics in children. J Med Virol. 2020; 92: 747–754.

Baj J, Karakuła V, Juchnowicz H. COVID19: Specific and non-specific clinical manifestations and symptoms: the current state of knowledge. J Clin Med. 2020; 9: 1753.

Larenas-Linnemann D, Luna-Pech J. Cutaneous manifestations related to COVID-19 immune dysregulation in the pediatric age group. Curr Allergy Asthma Rep. 2021; 21: 13.

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS. Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26: 1017-1032.

Criado PR, Abdalla BM, deAssis IC, van Blarcum G, Mello C, Caputo G, Vieira I. Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms. Inflamm Res. 2020; 69: 745–756.

Bourgonje AR, Abdulle AE, Timens W, Hillebrands JL, Navis GJ, Gordijn SJ. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020; 251: 228-248.

Gottlieb M, Long B. Dermatologic manifestations and complications of COVID-19. Am J Emerg Med. 2020; 38: 1715–1721.

Gianotti R, Zerbi P, Dodiuk-Gad RP. Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy. J Dermatol Sci. 2020; 98:141–143.

Roncati L, Ligabue G, Fabbiani L, Malagoli C, Gallo G, Lusenti B, etal. Type 3 hypersensitivity in COVID-19 vasculitis. Clin Immunol. 2020; 217: 108487.

GalvanCasas C, Catala A. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020; 183: 71-77.

Sharma S, Raby E, Kumarasinghe S. Cutaneous manifestations and dermatological sequelae of COVID-19 infection compared to those from other viruses. Australas J Dermatol. 2021; 10: 1111.

Garcia-Lara G, Linares-Gonzalez L, Rodenas-Herranz T, RuizVillaverde R. Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak. DermatolTher. 2020: 33: 13516.

Singh H, Kaur H. Cutaneous manifestations of COVID-19: a systematic review. Adv Wound Care. 2021; 1: 51-80.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395: 1417-1418.

Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB. COVID-19 and Kawasaki disease: novel virus and novel case. HospPediatr. 2020; 10: 537–540.

Kolivras A, Aeby A, Crow YJ. Cutaneous histopathological findings of Aicardi-Goutières syndrome, overlap with chilblain lupus. J Cutan Pathol. 2008; 35: 774-778.

Gonzalez Gonzalez F, Cortes Correa C, Penaranda Contreras E. Cutaneous manifestations in patients with COVID-19: clinical characteristics and possible pathophysiological mechanisms. Actas Dermosifiliogr 2021;112: 314-323.

Nasiri S, Dadkhahfar S, Abasifar H. Urticarial vasculitis in a COVID 19 recovered patient. Int J Dermatol. 2020; 59: 1285-1286.